MedinCell announces the availability of its 2019/2020 Universal Registration Document including the Annual Financial Report July 29, 2020 July 29, 2020
MedinCell announces the great success of its capital increase and raises 15.6 M€ June 16, 2020 June 16, 2020
MedinCell successfully renegotiates the drawdown conditions of the last tranche of the EIB loan and secures an additional €5m of non-dilutive funding June 10, 2020 June 10, 2020
MedinCell announces fiscal year consolidated results April 2019 – March 2020 June 4, 2020 June 4, 2020
Videoconference and publication of the results for the 2019-2020 financial year, on June 4, 2020 May 25, 2020 May 25, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis April 20, 2020 April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin April 6, 2020 April 6, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell January 28, 2020 January 28, 2020
